Nuwellis’ new CEO on building a strong foundation for sustainable value creation

Mike McCormick assumed the role of CEO at Nuwellis on 30 June, tasked with building on the company's positive Q1 2026 financial results. Nuwellis manufactures renal replacement therapy and fluid management devices for critical care settings. The leadership transition marks a shift in company strategy as McCormick focuses on sustainable value creation and operational foundation-building.